THE BETAMI-DANBLOCK TRIAL: RANDOMIZED DISCONTINUATION OF BETA-BLOCKERS AFTER MYOCARDIAL INFARCTION

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: HOT LINE 3 Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by